1 completed, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow TRC150094: new trials by email Literature Review of TRC150094 trials Research Report on TRC150094
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension TRC150094, Placebo - Diabetes, Dyslipidemias | Phase 3 | Unknown | Torrent Pharmaceuticals Limited | 1250 | 2018-03-12 | 2020-07-17 |
| Hyperinsulinemic Euglycemic Clamp Protocol TRC150094, Placebo - Metabolic Cardiovascular Syndrome | Phase 1 / Phase 2 | Completed | Torrent Pharmaceuticals Limited | 40 | 2011-11-01 | 2012-07-10 |
Diabetes Mellitus (1) · Dyslipidemias (1) · Hypertension (1) · Insulin Resistance (1) · Metabolic Syndrome (1)
Torrent Pharmaceuticals Limited (2)
Brazil (1) · India (1) · Netherlands (1) · Philippines (1)
Erik Stroes, MD, PhD (1) · Nikhil Tandon, M.D., PhD (1)